prostate epithelial cell growth kit (ATCC)
ATCC is a verified supplier
ATCC manufactures this product
Structured Review
Prostate Epithelial Cell Growth Kit, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prostate epithelial cell growth kit/product/ATCC
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Electrical Impedance Spectroscopy as a Tool to Detect the Epithelial to Mesenchymal Transition in Prostate Cancer Cells"
Article Title: Electrical Impedance Spectroscopy as a Tool to Detect the Epithelial to Mesenchymal Transition in Prostate Cancer Cells
Journal: bioRxiv
doi: 10.1101/2024.09.29.615724
Figure Legend Snippet: EIS experimental workflow for characterizing phenotype changes in PCCs. (1) Illustration of EMT in cancer cells. Initially, cells exhibit an epithelial phenotype characterized by the expression of E-cadherin and ZO-1. Then, the cells undergo downregulation of E-cadherin and ZO-1, transitioning to an intermediate phenotype. In this stage there is a shift in the protein expression profile with an upregulation of N-cadherin and vimentin leading to mesenchymal phenotype. (2) DU145, PC3, and LNCaP cells were obtained from cryogenic storage, thawed, and expanded in proliferation media. Cells were seeded with EMT-inducing media and allowed 5 days to incubate. (3) Cells were characterized using EIS and the 3DEP analyzer. A phenotype change was validated by a nuclei stain and immunofluorescence imaging. Figure created with Biorender.com .
Techniques Used: Expressing, Staining, Immunofluorescence, Imaging
Figure Legend Snippet: Normalized EIS cell analysis of EMT treated PCCs. (A) Average spectra of PC3 EMT-cells and PC3 EMT+ cells. (B) Average spectra of DU145 EMT-cells and DU145 EMT+ cells. Average spectra of (C) PC3 EMT- and PC3 EMT+ cells and (D) DU145 EMT-and DU145 EMT+ cells compared to epithelial and mesenchymal controls. Average normalized impedance of (E) PC3 EMT-and PC3+ cells and (F) DU145 EMT-and DU145 EMT+ cells compared to epithelial and mesenchymal controls. Error bars represent standard error mean. n=3 for PC3, DU145, epithelial control, and mesenchymal control cells. Statistical analysis completed on pooled data sets; ** p < 0.05, *** p < 0.001, and **** p < 0.0001.
Techniques Used: Cell Analysis, Control
Figure Legend Snippet: Morphology assessment of EMT treated PCCs. Phase contrast images overlayed with Hoechst-stained nuclei of PC3, DU145, and LNCaP cells without (EMT-) and with EMT (EMT+) treatment. The white arrows indicate a representative cell exhibiting characteristic epithelial morphology under EMT-conditions and mesenchymal morphology under EMT+ conditions.
Techniques Used: Staining
Figure Legend Snippet: Immunofluorescent staining of PCCs without and with EMT treatment (EMT- and EMT+, respectively). The staining highlights the expression of epithelial marker E-cadherin and mesenchymal marker vimentin both tagged with fluorescent labels. Quantification of fluorescent intensity for each marker is provided in the bar charts. Error bars represent standard error mean. n=3 for all conditions. Statistical analysis completed on pooled data sets; ** p < 0.05, and **** p < 0.0001.
Techniques Used: Staining, Expressing, Marker